#DrugPriceS

As breakthrough drugs offer critical hope to patients, lawmakers should focus on shoring up the social safety net

Welch said he would "not only vote for it, I would work actively and aggressively to make it happen."

Regeneron is the last of 17 companies the administration pressed to commit to the "most favored nation" policy.